Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinoma

BACKGROUND: Frequent disease relapse and a lack of effective therapies result in a very poor outcome in pancreatic ductal adenocarcinoma (PDAC) patients. Thus, identification of prognostic biomarkers and possible therapeutic targets is essential. Besides their function in cell–cell adhesion, desmogl...

Descripción completa

Detalles Bibliográficos
Autores principales: Ormanns, Steffen, Altendorf-Hofmann, Annelore, Jackstadt, Rene, Horst, David, Assmann, Gerald, Zhao, Yue, Bruns, Christiane, Kirchner, Thomas, Knösel, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815888/
https://www.ncbi.nlm.nih.gov/pubmed/26469831
http://dx.doi.org/10.1038/bjc.2015.362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815888/
https://www.ncbi.nlm.nih.gov/pubmed/26469831
http://dx.doi.org/10.1038/bjc.2015.362

Ejemplares similares